NCT03295500View on ClinicalTrials.gov

On the Cyberknife Dose Fraction of Liver Cancer Treatment

CompletedOBSERVATIONAL

Enrollment

657

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

September 10, 2021

Study Completion Date

September 24, 2021

Conditions

CyberKnife Radiosurgery

Interventions

RADIATION

Dose fraction forms

The investigators divide the participants randomly into 3 groups by SPSS 19.0.Three groups participants receive the different dose fraction(49Gy/7f,54Gy/6f and 55Gy/5f),which also means different Biologic Equivalent Dose.Through the research,the investigators want to find out the optimum dose fraction method,which makes the treatment safe, effective and personalized.

Trial Locations (1)

100039

CyberKnife, Beijing

All Listed Sponsors

lead

Beijing 302 Hospital

OTHER

NCT03295500 - On the Cyberknife Dose Fraction of Liver Cancer Treatment | Biotech Hunter | Biotech Hunter